Summit Therapeutics SMMT Business Segments — Other expenses
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Summit Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:SegmentReportingOtherItemAmount.
The official record: Summit Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Summit Therapeutics's business segments — other expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Summit Therapeutics's business segments — other expenses?
- Summit Therapeutics (SMMT) reported business segments — other expenses of $5.79M in Q1 2026.
- How has Summit Therapeutics's business segments — other expenses changed year-over-year?
- Summit Therapeutics's business segments — other expenses increased by 63.8% year-over-year, from $3.54M to $5.79M.
- What is the long-term trend for Summit Therapeutics's business segments — other expenses?
- Over 3 years (2022 to 2025), Summit Therapeutics's business segments — other expenses has grown at a -25.0% compound annual growth rate (CAGR), from $47.45M to $19.99M.
- What does business segments — other expenses mean?
- General operational costs not classified under major expense categories.
- How do you interpret business segments — other expenses?
- A significant increase may signal rising overhead or unforeseen operational inefficiencies that require management attention.
- How does business segments — other expenses compare across companies?
- Commonly found in segment reporting as 'Other' or 'Miscellaneous' operating expenses.